In the landmark Phase 3 VESALIUS-CV trial (12,000+ patients), adding Repatha to standard cholesterol-lowering therapy significantly reduced the risk of: Heart attacks Ischemic strokes Coronary deaths This makes Repatha the first PCSK9 inhibitor to demonstrate preventive benefits before heart disease strikes a true paradigm shift in cardiovascular care
The structural basis of cellulitethe arrangement of fibrous septae and fat chambersis not directly affected by the metabolic or hormonal changes induced by GLP-1 agonists
Patent drugs, also called patented drugs, represent the period where pharmaceutical companies enjoy market exclusivity before generics can enter
Frequently Asked Questions Will I lose muscle on Ozempic or Wegovy
High 5-oxoproline levels have also occasionally been reported with toxic acetaminophen levels (with or without acute liver toxicity) (10,19,24,29)
Pooled data from the STEP-HFpEF and STEP-HFpEF DM trials (totaling 1,145 participants) corroborated these findings: semaglutide led to significant increases in KCCQ-CSS scores, body weight reduction and improvements in secondary endpoints, including the 6MWD and inflammation markers [96]